Rhythm Pharmaceuticals, Inc.
RYTM· Nasdaq
Released Jul 29, 2019, after the close
10-Q filed Jul 29, 2019, 29 days after period end · 0001558370-19-006464
| Metric | Q2 2019 | Q2 2018 | Q2 2017 | Q2 2016 |
|---|---|---|---|---|
| Net Income | -$42.80M | -$14.41M | -$6.80M | -$5.73M |
| EPS Diluted | -$1.24 | -$0.52 | -$0.78 | -$0.64 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Rhythm Pharmaceuticals, Inc. · CIK 1649904 · Engraved from SEC EDGAR